[ad_1]
(MedPage Today) — Patients with pediatric non-infectious uveitis (NIU) who achieved remission on adalimumab (Humira) had lower recurrence rates when the drug was withdrawn more gradually, a retrospective cohort analysis indicated.
Recurrence…
[ad_2]
Source link : https://www.medpagetoday.com/rheumatology/arthritis/114962
Author :
Publish date : 2025-04-04 14:30:00
Copyright for syndicated content belongs to the linked Source.
Do This When Stopping Adalimumab in Pediatric Eye Disease
Related Posts
